Literature DB >> 19416861

PKR, a p53 target gene, plays a crucial role in the tumor-suppressor function of p53.

Cheol-Hee Yoon1, Eun-Soo Lee, Dae-Seog Lim, Yong-Soo Bae.   

Abstract

Type I IFN-induced expression of dsRNA-activated protein kinase (PKR) during viral infection is a well-established antiviral mechanism. However, little is known about the expression of PKR in the context of p53 and about PKR involvement in p53-mediated tumor suppression. Here, we report that PKR is a p53 target gene and plays an important role in the tumor-suppressor function of p53. Activation of p53 by genotoxic stress induces a significant level of PKR expression by acting on the newly identified cis-acting element (ISRE), which is separated from the IFN-stimulated responsive element on the PKR promoter, resulting in translational inhibition and cell apoptosis. The genotoxin-mediated inhibition of translation is associated with the p53/PKR/elF2a (eukaryotic initiation factor-2alpha) pathway. To some extent, p53 activation induced by DNA damage facilitates cell apoptosis by activating PKR. PKR-knockdown human colon cancer cells grew rapidly in nude mice and proved resistant to anti-cancer drugs. These data indicate that p53-mediated tumor suppression can be attributed at least in part to the biological functions of PKR induced by p53 in genotoxic conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19416861      PMCID: PMC2683089          DOI: 10.1073/pnas.0812148106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Definition of a consensus binding site for p53.

Authors:  W S el-Deiry; S E Kern; J A Pietenpol; K W Kinzler; B Vogelstein
Journal:  Nat Genet       Date:  1992-04       Impact factor: 38.330

2.  Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53.

Authors:  L Resnick-Silverman; S St Clair; M Maurer; K Zhao; J J Manfredi
Journal:  Genes Dev       Date:  1998-07-15       Impact factor: 11.361

Review 3.  p53, the cellular gatekeeper for growth and division.

Authors:  A J Levine
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

4.  Interferons in cancer therapy: a reappraisal.

Authors:  F R Balkwill; J F Smyth
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

5.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

6.  Isolation of the interferon-inducible RNA-dependent protein kinase Pkr promoter and identification of a novel DNA element within the 5'-flanking region of human and mouse Pkr genes.

Authors:  K L Kuhen; C E Samuel
Journal:  Virology       Date:  1997-01-06       Impact factor: 3.616

7.  p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa.

Authors:  Andreas Villunger; Ewa M Michalak; Leigh Coultas; Franziska Müllauer; Gunther Böck; Michael J Ausserlechner; Jerry M Adams; Andreas Strasser
Journal:  Science       Date:  2003-09-18       Impact factor: 47.728

8.  Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

Authors:  Akinori Takaoka; Sumio Hayakawa; Hideyuki Yanai; Dagmar Stoiber; Hideo Negishi; Hideaki Kikuchi; Shigeru Sasaki; Kohzoh Imai; Tsukasa Shibue; Kenya Honda; Tadatsugu Taniguchi
Journal:  Nature       Date:  2003-07-31       Impact factor: 49.962

Review 9.  Principles of tumor suppression.

Authors:  Charles J Sherr
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

10.  Transcriptional role of p53 in interferon-mediated antiviral immunity.

Authors:  César Muñoz-Fontela; Salvador Macip; Luis Martínez-Sobrido; Lauren Brown; Joseph Ashour; Adolfo García-Sastre; Sam W Lee; Stuart A Aaronson
Journal:  J Exp Med       Date:  2008-07-28       Impact factor: 14.307

View more
  57 in total

1.  Kip3-ing kinetochores clustered.

Authors:  Ryoma Ohi
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

2.  Rb/E2F1 regulates the innate immune receptor Toll-like receptor 3 in epithelial cells.

Authors:  Manabu Taura; Mary Ann Suico; Kosuke Koyama; Kensei Komatsu; Rui Miyakita; Chizuru Matsumoto; Eriko Kudo; Ryusho Kariya; Hiroki Goto; Shunsuke Kitajima; Chiaki Takahashi; Tsuyoshi Shuto; Mitsuyoshi Nakao; Seiji Okada; Hirofumi Kai
Journal:  Mol Cell Biol       Date:  2012-02-06       Impact factor: 4.272

3.  p53-derived host restriction of HIV-1 replication by protein kinase R-mediated Tat phosphorylation and inactivation.

Authors:  Cheol-Hee Yoon; Sang-Yoon Kim; Se Eun Byeon; Yideul Jeong; Jinjoo Lee; Kwang Pyo Kim; Jinseu Park; Yong-Soo Bae
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

4.  E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis.

Authors:  Ju Liu; C Zhang; X L Wang; P Ly; V Belyi; Z Y Xu-Monette; K H Young; W Hu; Z Feng
Journal:  Cell Death Differ       Date:  2014-08-22       Impact factor: 15.828

5.  Azasugar-containing phosphorothioate oligonucleotide (AZPSON) DBM-2198 inhibits human immunodeficiency virus type 1 (HIV-1) replication by blocking HIV-1 gp120 without affecting the V3 region.

Authors:  Jinjoo Lee; Se Eun Byeon; Ju Yeol Jung; Myeong-Ho Kang; Yu-Jin Park; Kyeong-Eun Jung; Yong-Soo Bae
Journal:  Mol Cells       Date:  2015-01-27       Impact factor: 5.034

6.  Translation control by protein kinase R restricts minute virus of mice infection: role in parvovirus oncolysis.

Authors:  Iván Ventoso; Juan J Berlanga; José M Almendral
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

7.  Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy.

Authors:  Xiaolei Li; Zhiqiang Wu; Xiaojing An; Qian Mei; Miaomiao Bai; Leena Hanski; Xiang Li; Tero Ahola; Weidong Han
Journal:  Elife       Date:  2017-08-18       Impact factor: 8.140

8.  The C proteins of human parainfluenza virus type 1 limit double-stranded RNA accumulation that would otherwise trigger activation of MDA5 and protein kinase R.

Authors:  Jim Boonyaratanakornkit; Emmalene Bartlett; Henrick Schomacker; Sonja Surman; Shizuo Akira; Yong-Soo Bae; Peter Collins; Brian Murphy; Alexander Schmidt
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

9.  New Cdc2 Tyr 4 phosphorylation by dsRNA-activated protein kinase triggers Cdc2 polyubiquitination and G2 arrest under genotoxic stresses.

Authors:  Cheol-Hee Yoon; Mohammad Alam Miah; Kwang Pyo Kim; Yong-Soo Bae
Journal:  EMBO Rep       Date:  2010-04-16       Impact factor: 8.807

Review 10.  The eIF2α kinases: their structures and functions.

Authors:  Neysan Donnelly; Adrienne M Gorman; Sanjeev Gupta; Afshin Samali
Journal:  Cell Mol Life Sci       Date:  2013-01-26       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.